Related Experiment Videos
Thrombolysis for obstructed CarboMedics mitral valve prosthesis
1Department of Internal Medicine, National Taiwan University Hospital, Taipei.
The Annals of Thoracic Surgery
|February 1, 1995
Summary
Prosthetic valve thrombosis, a rare but fatal complication, can be successfully treated with tissue-type plasminogen activator (tPA). Monitoring is effectively done using transthoracic and transesophageal echocardiography.
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Medical Imaging
Background:
- Prosthetic valve thrombosis (PVT) is a serious complication of mechanical heart valve replacement.
- Early diagnosis and treatment are crucial to prevent severe outcomes such as stroke or death.
Observation:
- This study focuses on the successful management of prosthetic valve thrombosis.
- The abstract highlights the use of specific diagnostic and therapeutic modalities.
Findings:
- Tissue-type plasminogen activator (tPA) demonstrates efficacy in treating prosthetic valve thrombosis.
- Transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE) are valuable tools for monitoring PVT treatment.
Implications:
- Successful treatment of PVT with tPA can improve patient outcomes and reduce mortality.
- Echocardiography plays a vital role in the surveillance and management of patients with prosthetic heart valves.